Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia
{{output}}
CLL1-targeted chimeric antigen receptor T (CAR-T) cell therapy has shown clinically meaningful activity in relapsed/refractory acute myeloid leukemia (R/R AML). This updated phase I study enrolled 38 adults with R/R AML to evaluate the safety and efficacy of t... ...
